

Author: Guan Xiao-Xu Zhou Yi Li Ji-Yao
Publisher: MDPI
E-ISSN: 1422-0067|12|7|4206-4213
ISSN: 1422-0067
Source: International Journal of Molecular Sciences, Vol.12, Iss.7, 2011-06, pp. : 4206-4213
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Hypertension is a risk factor for osteoporosis. Animal and epidemiological studies demonstrate that high blood pressure is associated with increased calcium loss, elevated parathyroid hormone, and increased calcium movement from bone. However, the mechanism responsible for hypertension-related osteoporosis remains elusive. Recent epidemiological studies indicate the benefits of Angiotensin II Receptors Blockade (ARB) on decreasing fracture risks. Since receptors for angiotensin II, the targets of ARB, are expressed in both osteoblasts and osteoclasts, we postulated that angiotensin II plays an important role in hypertension-related osteoporosis. Cbfa1 and RANKL, the important factors for maintaining bone homeostasis and key mediators in controlling osteoblast and osteoclast differentiation, are both regulated by cAMP-dependent signaling. Angiotensin II along with factors such as LDL, HDL, NO and homocysteine that are commonly altered both in hypertension and osteoporosis, can down-regulate the expression of Cbfa1 but up-regulate RANKL expression via the cAMP signaling pathway. We thus hypothesized that, by altering the ratio of Cbfa1/RANKL expression via the cAMP-dependent pathway, angiotensin II differently regulates osteoblast and osteoclast differentiation leading to enhanced bone resorption and reduced bone formation. Since ARB can antagonize the adverse effect of angiotensin II on bone by lowering cAMP levels and modifying other downstream targets, including LDL, HDL, NO and Cbfa1/RANKL, we propose the hypothesis that the antagonistic effects of ARB may also be exerted via cAMP signaling pathway.
Related content


By Collister John P. Bellrichard Mitch Drebes Donna Nahey David Tian Jun Zimmerman Matthew C.
International Journal of Molecular Sciences, Vol. 15, Iss. 12, 2014-12 ,pp. :


By Xu Hong-Zhao Cheng Yan-Li Wang Wan-Ning Wu Hao Zhang Yuan-Yuan Zang Chong-Sen Xu Zhong-Gao
International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. :




By Kim Hyosang Baek Chung Hee Lee Raymond Bok Chang Jai Won Yang Won Seok Lee Sang Koo
International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. :


By Hwang Ok-Kyung Park Jin-Kyu Lee Eun-Joo Lee Eun-Mi Kim Ah-Young Jeong Kyu-Shik
International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. :